This book is a research retrospective that provides a critical examination of a senior pharmacy practice researcher's extensive body of work. It offers a rare glimpse into the scientific journey, highlighting not only the findings but also the candid reflections on what was achieved, what was missed, and what remains to be explored. Each of the twelve chapters is meticulously structured to include a scientific story, a critical reflection, and a forward-looking Research Agenda Note, posing five open questions for the next generation of researchers.
The book examines key topics such as pharmaceutical care in the Middle East, patient-reported outcomes in asthma and chronic kidney disease, medication-related burden, and the impact of COVID-19 on medicine access. It spans research conducted across New Zealand, Qatar, and the UAE, offering a multi-country perspective that enriches the discourse on pharmacy practice and its relevance to an international audience.
This scholarly work is essential for pharmacy academics, health services researchers, graduate students, and policy-focused practitioners seeking more than data. It offers rare candor often absent from academic publications, promoting transparency and reflexivity in health research. The specific open questions aimed at guiding future research in each chapter also make it forward-looking, positioning the book as a distinctive and impactful contribution to pharmacy practice literature.
This book is a research retrospective that provides a critical examination of a senior pharmacy practice researcher's extensive body of work. It offers a rare glimpse into the scientific journey, highlighting not only the findings but also the candid reflections on what was achieved, what was missed, and what remains to be explored. Each of the twelve chapters is meticulously structured to include a scientific story, a critical reflection, and a forward-looking Research Agenda Note, posing five open questions for the next generation of researchers.
The book examines key topics such as pharmaceutical care in the Middle East, patient-reported outcomes in asthma and chronic kidney disease, medication-related burden, and the impact of COVID-19 on medicine access. It spans research conducted across New Zealand, Qatar, and the UAE, offering a multi-country perspective that enriches the discourse on pharmacy practice and its relevance to an international audience.
This scholarly work is essential for pharmacy academics, health services researchers, graduate students, and policy-focused practitioners seeking more than data. It offers rare candor often absent from academic publications, promoting transparency and reflexivity in health research. The specific open questions aimed at guiding future research in each chapter also make it forward-looking, positioning the book as a distinctive and impactful contribution to pharmacy practice literature.
Nadir Kheir
Patient-reported outcomes pharmacy Medication-related burden Pharmaceutical care evaluation Pharmacy education Middle East PROMs chronic disease Health outcomes research Pharmacy practice research